CRO Aviano - National Cancer Institute
Identify suitable pharmacological targets used in the clinical practice, and investigate their physico-chemical properties. Identify the best methodologies and technologies to modified suitable platform aiming at developing biosensors that are capable of detecting the pharmacological targets. Develop a lab “demonstrator” device to detect and quantify the targets under investigation in a spiked sample and in a real sample from a patient under chemotherapic treatment.
CRO Aviano – National Cancer Institute is a Research Institute committed to carry out cancer research and provide medical treatment and assistance to patients. Its goals include progress in Public Health by contributing to medical knowledge, while providing excellence to patients in cancer treatment and high education standard to young researchers, graduates, postdocs in the field of oncology.